Mindray DPM5 Monitor, a vital signs monitor used on human patients in healthcare facilities.
Class I - DangerousWhat Should You Do?
- Check if you have this product: p/n 9201F-PA000XX DS- 0C000565 02000335 12000603 12000599 12000597 OCOOO569 9A000247 9A000252 17000648 06000490 05000470 05000466 02000373
- Do not eat it: Even if it looks and smells fine, do not consume this product.
- Throw it away or return it: You can return the product to the store for a full refund.
- Seek medical attention if needed: If you've consumed this product and feel unwell, contact your doctor immediately.
- Report problems: Report any issues to the FDA's Safety Reporting Portal.
⚠️ Emergency: If you experience severe symptoms after consuming this product, call 911 or Poison Control at 1-800-222-1222.
Recall Details
- Company:
- Mindray DS USA, Inc. d.b.a. Mindray North America
- Reason for Recall:
- Mindray has identified an issue with the DPM5 monitors where ST and Arrhythmia features may not be available.
- Classification:
- Class I - Dangerous
Dangerous or defective products that predictably could cause serious health problems or death.
- Status:
- terminated
Product Information
Full Description:
Mindray DPM5 Monitor, a vital signs monitor used on human patients in healthcare facilities.
Product Codes/Lot Numbers:
p/n 9201F-PA000XX DS- 0C000565 02000335 12000603 12000599 12000597 OCOOO569 9A000247 9A000252 17000648 06000490 05000470 05000466 02000373
Official Source
Always verify recall information with the official FDA source:
View on FDA.govFDA Recall Number: Z-0742-2013
Related Recalls
BS-200 Chemistry Analyzer Designed for clinical laboratory use.
Mindray DS USA, Inc. d.b.a. Mindray North America
An issue has been identified with the BS-200 where clinical chemistry results may be inaccurate.
Mindray DS USA, Inc., DPM Central Monitoring System with ambulatory Telepack. Part numbers: 300BF-PA00002, and 300BF-PA00003 (DPM Central Monitoring System) 115-006908-01, -03, -04 (DPM software upgrade kit). The DPM Central Monitoring System transfers information between DPM Central station and other networked devices.
Mindray DS USA, Inc. d.b.a. Mindray North America
Mindray has identified a software anomaly that may where, in the presence of an asystole, the Telepack ECG waveform may produce a unique step pattern (instead of a flat line) if Lead 1 or V is being utilized for detecting cardiac arrhythmia.
There is a software anomaly with the DPM Central Monitoring System where the trend data of one patient maybe replaced with the trend data of a second patient.